Approved Symbol |
Approved Name |
Location |
Type |
No. of Association Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
ADCY8 |
adenylate cyclase 8 (brain) |
8q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
TAS
|
TRHDE |
thyrotropin-releasing hormone degrading enzyme |
12q21.1 |
Mapped by LD-proxy |
0
|
TAS[10491199]
|
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
10q21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(2/0/0)
|
IEA
|
ARHGAP21 |
Rho GTPase activating protein 21 |
10p12.31 |
rSNP target |
0
|
IEA
|
IL1B |
interleukin 1 beta |
2q14 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
TAS[9218611|10786823]
|
FASLG |
Fas ligand |
1q23 |
Literature-origin |
1(0/0/1)
|
TAS[7826947]
|
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
5q31-q32 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
6(2/4/0)
|
TAS[7769088]
|
CHRNA6 |
cholinergic receptor, nicotinic alpha 6 |
8p22 |
Literature-origin, Mapped by Literature SNP |
1(0/1/0)
|
TAS[8906617]
|
NOD1 |
nucleotide binding oligomerization domain containing 1 |
7p14.3 |
rSNP target |
0
|
TAS[15967716]
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
1q44 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IMP[18524868]
|
STMN1 |
stathmin 1 |
1p36.11 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
6(1/5/0)
|
NAS[8003023]
|
GULP1 |
GULP, engulfment adaptor PTB domain containing 1 |
2q32.3-q33 |
Mapped by LD-proxy, rSNP target |
0
|
TAS[10574763|10574771]
|
LTB |
lymphotoxin beta |
6p21.3 |
rSNP target |
0
|
TAS[7916655]
|
CHRNA2 |
cholinergic receptor, nicotinic alpha 2 |
8p21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
IDA[8906617]
|
LTA |
lymphotoxin alpha |
6p21.3 |
Mapped by Literature SNP |
0
|
TAS[6334807]
|
CHRNA5 |
cholinergic receptor, nicotinic alpha 5 |
15q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
2(1/1/0)
|
NAS[9009220]
|
PRKCA |
protein kinase C, alpha |
17q24.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
10(9/0/1)
|
TAS
|
CHRNA7 |
cholinergic receptor, nicotinic alpha 7 |
15q13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
IDA[8906617]
|
PRKG1 |
protein kinase, cGMP-dependent, type I |
10q11.2 |
Literature-origin, Mapped by Literature SNP |
1(0/0/1)
|
TAS[2792381]
|
IL15RA |
interleukin 15 receptor subunit alpha |
10p15.1 |
rSNP target |
0
|
TAS[8530383]
|
SERGEF |
secretion regulating guanine nucleotide exchange factor |
11p14.3 |
Mapped by LD-proxy, rSNP target |
0
|
TAS[10571079]
|
PTPRT |
protein tyrosine phosphatase, receptor type T |
20q12-q13 |
Literature-origin, Mapped by Literature SNP |
1(0/0/1)
|
NAS[16973135]
|
PENK |
proenkephalin |
8q12.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(1/1/0)
|
TAS[7057924]
|
CLIC1 |
chloride intracellular channel 1 |
6p21.3 |
rSNP target |
0
|
TAS[16130169]
|
CRHBP |
corticotropin releasing hormone binding protein |
5q13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
TAS[7477348]
|
CCK |
cholecystokinin |
3p22.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
TAS[10320330]
|
ARHGAP27 |
Rho GTPase activating protein 27 |
17q21.31 |
rSNP target |
0
|
IEA
|
RNF14 |
ring finger protein 14 |
5q23.3-q31.1 |
rSNP target |
0
|
TAS[10085091]
|
PTK2B |
protein tyrosine kinase 2 beta |
8p21.1 |
Mapped by LD-proxy |
0
|
TAS[7499242|10867021]
|
NRXN3 |
neurexin 3 |
14q31 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
NAS[18923512]
|
CHRNA3 |
cholinergic receptor, nicotinic alpha 3 |
15q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(0/1/0)
|
IDA[8906617]
|
CHRNB4 |
cholinergic receptor, nicotinic beta 4 |
15q24 |
Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
0
|
IDA[8906617]
|
CHRNA4 |
cholinergic receptor, nicotinic alpha 4 |
20q13.33 |
Literature-origin |
1(1/0/0)
|
IDA[8906617]
|
CHRNB3 |
cholinergic receptor, nicotinic beta 3 |
8p11.21 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
TAS[7690916]
|